Acutus Medical has announced the appointment of three new executive team members. John Dahldorf, Martin Chambers and Steven McQuillan join the company as chief financial officer, chief commercial officer and senior vice president, Regulatory and Clinical Affairs, respectively.
“John, Martin and Steven come to us with the technical and commercial experience necessary to transform Acutus Medical from an early stage start-up company to a full commercial entity,” said Randy Werneth, president and chief executive officer of Acutus Medical. “With their leadership and knowledge and our existing bench strength, we are confident that Acutus Medical will revolutionise the electrophysiology market and realise the full potential of our broad portfolio of products, including the AcQMap high resolution, imaging and mapping system.”
Dahldorf has more than 30 years of financial, operational and leadership experience in the healthcare industry. He brings comprehensive knowledge of acquisitions and initial public offerings, as well as development and execution of strategic plans to the company. Dahldorf joins Acutus Medical from Volcano Corporation (formerly Volcano Therapeutics), where he held positions as the chief finance officer, principal accounting officer, general manager and secretary since 2003.
Chambers joins Acutus Medical with more than 30 years of sales and marketing experience, focused primarily on the global commercialisation of implantable cardiac devices and peripheral/cardiac vascular interventional devices. Chambers has held a number of executive sales and marketing positions throughout his career with leading medical device companies including Guidant Corporation, EV3 (acquired by Covidien), Medtronic, Ablation Frontiers (acquired by Medtronic) and, most recently, Spinal Modulation (acquired by St. Jude Medical).
McQuillan brings over 25 years of experience in clinical trial design and execution, as well as a deep understanding of the global medical device regulatory environment. Prior to joining Acutus Medical,. McQuillan served as senior vice president of Clinical and Regulatory Affairs at Spinal Modulation, (acquired by St. Jude Medical), and has held several key leadership positions at the University of Minnesota, Department of Surgery, CPI/Guidant, Boston Scientific and Medtronic (Atrial Fibrillation Solutions).
